Abstract
Overexpression of the MYC protooncogene has been implicated in the genesis of diverse human tumors. Tumorigenesis induced by MYC has been attributed to sustained effects on proliferation and differentiation. Here we report that MYC may also contribute to tumorigenesis by destabilizing the cellular genome. A transient excess of MYC activity increased tumorigenicity of Rat1A cells by at least 50-fold. The increase persisted for >30 days after the return of MYC activity to normal levels. The brief surfeit of MYC activity was accompanied by evidence of genomic instability, including karyotypic abnormalities, gene amplification, and hypersensitivity to DNA-damaging agents. MYC also induced genomic destabilization in normal human fibroblasts, although these cells did not become tumorigenic. Stimulation of Rat1A cells with MYC accelerated their passage through G 1 /S. Moreover, MYC could force normal human fibroblasts to transit G 1 and S after treatment with N- (phosphonoacetyl)- l -aspartate (PALA) at concentrations that normally lead to arrest in S phase by checkpoint mechanisms. Instead, the cells subsequently appeared to arrest in G 2 . We suggest that the accelerated passage through G 1 was mutagenic but that the effect of MYC permitted a checkpoint response only after G 2 had been reached. Thus, MYC may contribute to tumorigenesis through a dominant mutator effect.
References
30
Referenced
333
10.1016/0092-8674(91)90636-D
10.1016/S0092-8674(00)81333-1
10.1126/science.7801122
10.1126/science.274.5293.1664
10.1016/S0092-8674(00)81870-X
10.1126/science.7997877
10.1016/0955-0674(95)80066-2
10.1146/annurev.bi.61.070192.004113
- S Mai, J Hanley-Hyde, M Fluri Oncogene 12, 277–288 (1996). / Oncogene by Mai S (1996)
10.1007/BF02257272
- C Cerni, E Mougneau, M Zerlin, M Julius, K B Marcu, F Cuzin Curr Top Microbiol Immunol 132, 193–201 (1986). / Curr Top Microbiol Immunol by Cerni C (1986)
10.1128/MCB.18.1.536
10.1038/340066a0
10.1016/0022-1759(82)90269-1
10.1016/S1067-2389(96)80055-0
10.1128/mcb.7.5.1638-1645.1987
10.1073/pnas.90.16.7804
10.1101/gad.5.2.160
10.1073/pnas.93.10.4827
- J Karn, J V Watson, A D Lowe, S M Green, W Vedeckis Oncogene 4, 773–787 (1989). / Oncogene by Karn J (1989)
- P Zhou, W Jiang, C M Weghorst, I B Weinstein Cancer Res 56, 36–39 (1996). / Cancer Res by Zhou P (1996)
10.1073/pnas.91.11.5124
10.1128/MCB.17.1.506
- D Mumberg, K Haas, T Möröy, R Niedenthal, J H Hegemann, M Funk, R Müller Oncogene 13, 2493–2497 (1996). / Oncogene by Mumberg D (1996)
10.1128/MCB.18.5.3089
- H Hermeking, J O Funk, M Reichert, J W Ellwart, D Eick Oncogene 11, 1409–1415 (1995). / Oncogene by Hermeking H (1995)
10.1093/emboj/16.17.5322
10.1038/sj.onc.1201138
10.1038/386623a0
- A E Coleman, E Schröck, Z Weaver, S du Manoir, F Yang, M A Ferguson-Smith, T Ried, S Janz Cancer Res 57, 4585–4592 (1997). / Cancer Res by Coleman A E (1997)
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 26, 2002, 10:35 a.m.) |
Deposited | 3 years, 4 months ago (April 13, 2022, 5:41 p.m.) |
Indexed | 1 month, 4 weeks ago (July 1, 2025, 9:30 a.m.) |
Issued | 26 years, 5 months ago (March 30, 1999) |
Published | 26 years, 5 months ago (March 30, 1999) |
Published Online | 26 years, 5 months ago (March 30, 1999) |
Published Print | 26 years, 5 months ago (March 30, 1999) |
@article{Felsher_1999, title={Transient excess of MYC activity can elicit genomic instability and tumorigenesis}, volume={96}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.96.7.3940}, DOI={10.1073/pnas.96.7.3940}, number={7}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Felsher, Dean W. and Bishop, J. Michael}, year={1999}, month=mar, pages={3940–3944} }